Back to results
US 2025/0205231 A1Published application
Tear Film Stability
OwnerKenneth Gek-Jin OOI, Stephanie Louise WATSONinventors
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method of stabilising a tear film in an individual having an ocular surface inflammatory disorder by providing a compound to an ocular surface of the individual to reduce the synthesis of a cholesterol by a meibum producing tissue.
Claims10
A method of stabilising a tear film in an individual having an ocular surface inflammatory disorder including:
- providing an individual having an ocular surface inflammatory disorder that is characterised by an unstable tear film, wherein the disorder is posterior blepharitis associated with meibomian gland dysfunction;
- and
- providing a compound to an ocular surface of the individual to reduce the synthesis of a cholesterol by a meibum-producing tissue, wherein the compound is atorvastatin;
- thereby stabilising the tear film in the individual,
- wherein atorvastatin is applied in an amount equivalent to 1 to 15 drops per day from a 50 μM atorvastatin solution.
2 more elements
Dependencies are inferred from the claim text.